Christopher P. Lowe - 13 May 2021 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Director
Signature
By: /s/ Christopher P. Lowe
Issuer symbol
VINC
Transactions as of
13 May 2021
Net transactions value
$0
Form type
4
Filing time
14 May 2021, 17:23:59 UTC
Next filing
30 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 13 May 2021 Common Stock 20,000 $16.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of May 13, 2022, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service.